Health insurers are limiting which drugs they'll cover, in a bid to limit drug costs. Tom Werner/Getty Images hide caption
drug costs drug costs
Stories About
drug costs
Zolgensma, a new drug approved by the FDA Friday, costs more than $2.1 million. It's made by AveXis, a drugmaker owned by pharmaceutical giant Novartis. Bloomberg/Bloomberg via Getty Images hide caption
A new book, Bottle of Lies, reveals serious safety and purity concerns about the global generic-drug supply. Tetra Images/Getty Images hide caption
The Generic Drugs You're Taking May Not Be As Safe Or Effective As You Think
Oakley Yoder walks with her parents, Josh Perry and Shelli Yoder, outside their home in Bloomington, Ind. Chris Bergin for KHN hide caption
Drug prices in the United States support spending on research and development, said AbbVie CEO Richard Gonzalez (far left) in testimony by drug company executives before the Senate Finance Committee on Tuesday. Pablo Martinez Monsivais/AP hide caption
Sen. Estes Kefauver, D-Tenn., (left) and Sen. Everett Dirksen, R-Ill., (second from left) clashed at the reopening of a Senate drug investigation in 1960 over whether witnesses could be forced to reveal business secrets while testifying. Bettmann Archive/Getty Images hide caption
Shereese Hickson was diagnosed with multiple sclerosis in 2012 and is unable to work. She supports herself and her son, Isaiah, on $770 a month. Shane Wynn for KHN hide caption
Chronically Ill, Traumatically Billed: $123,019 For 2 Multiple Sclerosis Treatments
President Trump announces a plan to overhaul how Medicare pays for certain drugs during a Thursday speech at the Department of Health and Human Services in Washington, D.C. Chip Somodevilla/Getty Images hide caption
Health insurers who offer Medicare Advantage plans have permission to soon require patients to try less expensive alternatives to some before receiving pricier drugs. Witthaya Prasongsin/Getty Images hide caption
Massachusetts wanted to negotiate prices and stop the use of some of the most expensive drugs in its Medicaid program. The federal government said no. Paul Marotta/Getty Images hide caption
Patient Aaron Reid receives (CAR) T-cell therapy at the NIH in Bethesda, MD. The process took five minutes to complete. Pearl Mak/NPR hide caption
Drug costs are the fastest growing part of state Medicaid budgets. asiseeit/Getty Images hide caption
States Question Costs Of Middlemen That Manage Medicaid Drug Benefits
Dr. Ronald Cirillo helps Deborah Hatfield fill out paperwork at a Florida clinic, before running a test to see whether she has hepatitis C. Daylina Miller/Health News Florida hide caption
The new law will require pharmaceutical companies to notify the state and health insurers if they plan to raise the price of a medication by 16 percent or more over two years. fotostorm/Getty Images hide caption
Drug lobbyists and consumer health advocates fill the halls of the state Capitol in September to see how Assembly members vote on a controversial drug price transparency bill. Tam Ma/Courtesy of Health Access California hide caption
FDA Commissioner Scott Gottlieb says the agency will close a loophole that lets drug manufacturers skip pediatric testing in some drugs intended for children. Zach Gibson/Getty Images hide caption
Lee Cantrell, an associate professor of clinical pharmacology at the University of California, San Diego, with a collection of vintage expired medications. Sandy Huffaker for ProPublica hide caption
French pharmaceutical group Sanofi is expected to receive an exclusive license to market a new Zika vaccine. AFP/AFP/Getty Images hide caption
States Fear Price Of New Zika Vaccine Will Be More Than They Can Pay
Pharmaceutical companies send "detailers" to hospitals to persuade doctors to prescribe their medications. IPGGutenberg UK Ltd/Getty Images/iStockphoto hide caption
If you make a mistake in estimating your yearly income, you may have to pay back the subsidy you get for health insurance. Guido Mieth/Getty Images hide caption